These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 15019338

  • 1. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S, Flaherty M, Billson F, North K.
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [Abstract] [Full Text] [Related]

  • 2. Optic radiation involvement in optic pathway gliomas in neurofibromatosis.
    Liu GT, Brodsky MC, Phillips PC, Belasco J, Janss A, Golden JC, Bilaniuk LL, Burson GT, Duhaime AC, Sutton LN.
    Am J Ophthalmol; 2004 Mar; 137(3):407-14. PubMed ID: 15013861
    [Abstract] [Full Text] [Related]

  • 3. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
    Lama G, Esposito Salsano M, Grassia C, Calabrese E, Grassia MG, Bismuto R, Melone MA, Russo S, Scuotto A.
    Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
    [Abstract] [Full Text] [Related]

  • 4. Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1.
    Sylvester CL, Drohan LA, Sergott RC.
    Curr Opin Ophthalmol; 2006 Feb; 17(1):7-11. PubMed ID: 16436918
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
    Kelly JP, Leary S, Khanna P, Weiss AH.
    Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
    [Abstract] [Full Text] [Related]

  • 6. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC.
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [Abstract] [Full Text] [Related]

  • 7. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
    Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR.
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
    [Abstract] [Full Text] [Related]

  • 8. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
    Kinori M, Armarnik S, Listernick R, Charrow J, Zeid JL.
    Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
    [Abstract] [Full Text] [Related]

  • 9. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
    Campagna M, Opocher E, Viscardi E, Calderone M, Severino SM, Cermakova I, Perilongo G.
    Pediatr Blood Cancer; 2010 Dec 01; 55(6):1083-8. PubMed ID: 20979170
    [Abstract] [Full Text] [Related]

  • 10. Natural history and outcome of optic pathway gliomas in children.
    Nicolin G, Parkin P, Mabbott D, Hargrave D, Bartels U, Tabori U, Rutka J, Buncic JR, Bouffet E.
    Pediatr Blood Cancer; 2009 Dec 15; 53(7):1231-7. PubMed ID: 19621457
    [Abstract] [Full Text] [Related]

  • 11. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
    Kuenzle C, Weissert M, Roulet E, Bode H, Schefer S, Huisman T, Landau K, Boltshauser E.
    Neuropediatrics; 1994 Dec 15; 25(6):295-300. PubMed ID: 7770126
    [Abstract] [Full Text] [Related]

  • 12. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
    Schröder S, Baumann-Schröder U, Hazim W, Haase W, Mautner VF.
    Klin Monbl Augenheilkd; 1999 Dec 15; 215(6):349-54. PubMed ID: 10637799
    [Abstract] [Full Text] [Related]

  • 13. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E, Décarie JC, Marzouki M, Carret AS, Ospina LH.
    Pediatr Blood Cancer; 2014 Feb 15; 61(2):223-7. PubMed ID: 23956233
    [Abstract] [Full Text] [Related]

  • 14. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
    Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, Evans DG.
    J Clin Oncol; 2006 Jun 01; 24(16):2570-5. PubMed ID: 16735710
    [Abstract] [Full Text] [Related]

  • 15. [Neurofibromatosis type 1 and optic pathway gliomas. A series of 80 patients].
    Pascual-Castroviejo I, Pascual-Pascual SI, Velázquez-Fragua R, Viaño J, García-Segura JM, Botella MP.
    Rev Neurol; 2006 Jun 01; 46(9):530-6. PubMed ID: 18446694
    [Abstract] [Full Text] [Related]

  • 16. [Optic pathway gliomas in patients with neurofibromatosis type 1: clinical-neuroradiological integrated approach].
    Zuccoli G, Ferrozzi F, Signorini M, Virdis R, Troiso A.
    Radiol Med; 2001 May 01; 101(5):382-5. PubMed ID: 11438792
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Neurofibromatosis type 1: a survey of 195 patients].
    Overweg-Plandsoen WC, Weersink RG, Sillevis Smitt JH, Fleury P, van Asperen CJ.
    Ned Tijdschr Geneeskd; 1997 Mar 29; 141(13):624-9. PubMed ID: 9127578
    [Abstract] [Full Text] [Related]

  • 20. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
    Oh KS, Hung J, Robertson PL, Garton HJ, Muraszko KM, Sandler HM, Hamstra DA.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e481-8. PubMed ID: 21470783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.